Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 4, 2012, Pages 1704-1709

  de Moraes, Carlos Gustavo ^a,b   Demirel, Shaban ^c   Gardiner, Stuart K ^c   Liebmann, Jeffrey M ^a,b   Cioffi, George A ^c   Ritch, Robert ^a,d   Gordon, Mae O ^e   Kass, Michael A ^e  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEVERS EYE INSTITUTE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; INCIDENCE; INTRAOCULAR HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADMINISTRATION, TOPICAL; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; OBSERVATION; OCULAR HYPERTENSION; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84859416420     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8186     Document Type: Article

References (27)

1. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 1999;117:573-583.
2. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
3. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
4. Gordon MO, Torri V, Miglior S, et al. Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology. 2007;114:10-19.
5. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965-1972.
6. Investigators. AGIS. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:490-491.
7. Musch DC, Gillespie BW, Lichter PR, et al. Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200-207.
8. Miglior S, Torri V, Zeyen T, et al. Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol. 2007;144:266-275.
9. Medeiros FA, Sample PA, Zangwill LM, et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol. 2003;136:805-813.
10. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699-708.
11. Parrish RK II, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115:1447-1455.
12. Henson DB, Chaudry S, Artes PH, et al. Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. Invest Ophthalmol Vis Sci. 2000;41:417-421.
13. Caprioli J. The importance of rates in glaucoma. Am J Ophthalmol. 2008;145:191-192.
14. Fitzke FW, Hitchings RA, Poinoosawmy D, et al. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996; 80:40-48.
15. Manassakorn A, Nouri-Mahdavi K, Koucheki B, et al. Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities. Invest Ophthalmol Vis Sci. 2006;47:2896-2903.
16. Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43:1400-1407.
17. Spry PG, Bates AB, Johnson CA, et al. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci. 2000;41:2192-2200.
18. Budenz DL, Rhee P, Feuer WJ, et al. Comparison of glaucomatous visual field defects using standard full threshold and Swedish interactive threshold algorithms. Arch Ophthalmol. 2002;120:1136-1141.
19. Wild JM, Pacey IE, Hancock SA, et al. Between-algorithm, between-individual differences in normal perimetric sensitivity: full threshold, FASTPAC, and SITA. Swedish Interactive Threshold algorithm. Invest Ophthalmol Vis Sci. 1999;40: 1152-1161.
20. Chauhan BC, Garway-Heath DF, Gõni FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92:569-573.
21. Kass MA, Gordon MO, Gao F, et al. Delaying treatment of ocular hypertension: The Ocular Hypertension Treatment Study. Arch Ophthalmol. 2010;128:276-287.
22. Gordon MO, Torri V, Miglior S, et al. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology. 2007; 114:10-19.
23. Medeiros FA, Weinreb RN, Zangwill LM, et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology. 2008;115: 934-940.
24. Folgar FA, De Moraes CG, Prata TS, et al. Glaucoma surgery decreases the velocity of localized and global visual field progression. Am J Ophthalmol. 2010;149:258-264.
25. Heijl A, Bengtsson B, Hyman L, et al. Natural history of openangle glaucoma. Ophthalmology. 2009;116:2271-2276.
26. McKean-Cowdin R, Varma R, Wu J, et al. Severity of visual field loss and health-related quality of life. Am J Ophthalmol. 2007; 143:1013-1023.
27. Bengtsson B, Patella VM, Heijl A. Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol. 2009;127:1610-1615.